Vascular Endothelial Growth Factor and Angiogenesis
Top Cited Papers
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 56 (4) , 549-580
- https://doi.org/10.1124/pr.56.4.3
Abstract
Angiogenesis is a hallmark of wound healing, the menstrual cycle, cancer, and various ischemic and inflammatory diseases. A rich variety of pro- and antiangiogenic molecules have already been discovered. Vascular endothelial growth factor (VEGF) is an interesting inducer of angiogenesis and lymphangiogenesis, because it is a highly specific mitogen for endothelial cells. Signal transduction involves binding to tyrosine kinase receptors and results in endothelial cell proliferation, migration, and new vessel formation. In this article, the role of VEGF in physiological and pathological processes is reviewed. We also discuss how modulation of VEGF expression creates new therapeutic possibilities and describe recent developments in this field.Keywords
This publication has 226 references indexed in Scilit:
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002
- Relative effects of VEGF‐A and VEGF‐C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin‐1Journal of Cellular Biochemistry, 2002
- Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritisArthritis & Rheumatism, 2001
- Vascular Endothelial Growth Factor-C and Its Receptor VEGFR-3 in the Nasal Mucosa and in Nasopharyngeal TumorsThe American Journal of Pathology, 2000
- Vegf, vegf-B, vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosaInternational Journal of Cancer, 2000
- Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cellsInternational Journal of Cancer, 1999
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993